CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC
- DOI
- 10.1038/s44318-026-00854-5
- Published
- 2026-07-11
- Container
- The EMBO Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s44318-026-00854-5,
title = {CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC},
author = {Kathleen M McAndrews and Krishnan K Mahadevan and Bingrui Li and Anaïs M Comptdaer and Amari M Sockwell and Sami J Morse and Patience J Kelly and Sarah I Patel and Michelle L Kirtley and Barbara A Moreno Diaz and Hengyu Lyu and David H Peng and Sima Khazaei and Aislyn Schalck and Xunian Zhou and Hikaru Sugimoto and Aaron A Bickert and Lakshmi Kavitha Sthanam and Meagan R Taylor and Shreyasee V Kumbhar and Kent A Arian and Yasaman Barekatain and Francesca Paradiso and Paola A Guerrero and Vincent Bernard and Navid Sobhani and Alondra N Camacho-Acevedo and Kiara E Bornes and Phuong Thao Tran and Anirban Maitra and Timothy P Heffernan and Raghu Kalluri},
year = {2026},
journal = {The EMBO Journal},
doi = {10.1038/s44318-026-00854-5},
url = {https://doi.org/10.1038/s44318-026-00854-5}
}RIS
TY - JOUR TI - CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC AU - Kathleen M McAndrews AU - Krishnan K Mahadevan AU - Bingrui Li AU - Anaïs M Comptdaer AU - Amari M Sockwell AU - Sami J Morse AU - Patience J Kelly AU - Sarah I Patel AU - Michelle L Kirtley AU - Barbara A Moreno Diaz AU - Hengyu Lyu AU - David H Peng AU - Sima Khazaei AU - Aislyn Schalck AU - Xunian Zhou AU - Hikaru Sugimoto AU - Aaron A Bickert AU - Lakshmi Kavitha Sthanam AU - Meagan R Taylor AU - Shreyasee V Kumbhar AU - Kent A Arian AU - Yasaman Barekatain AU - Francesca Paradiso AU - Paola A Guerrero AU - Vincent Bernard AU - Navid Sobhani AU - Alondra N Camacho-Acevedo AU - Kiara E Bornes AU - Phuong Thao Tran AU - Anirban Maitra AU - Timothy P Heffernan AU - Raghu Kalluri PY - 2026 JO - The EMBO Journal DO - 10.1038/s44318-026-00854-5 UR - https://doi.org/10.1038/s44318-026-00854-5 ER -
APA
McAndrews, K. M., Mahadevan, K. K., Li, B., Comptdaer, A. M., Sockwell, A. M., Morse, S. J., Kelly, P. J., Patel, S. I., Kirtley, M. L., Diaz, B. A. M., Lyu, H., Peng, D. H., Khazaei, S., Schalck, A., Zhou, X., Sugimoto, H., Bickert, A. A., Sthanam, L. K., Taylor, M. R., Kumbhar, S. V., Arian, K. A., Barekatain, Y., Paradiso, F., Guerrero, P. A., Bernard, V., Sobhani, N., Camacho-Acevedo, A. N., Bornes, K. E., Tran, P. T., Maitra, A., Heffernan, T. P., & Kalluri, R. (2026). CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC. The EMBO Journal. https://doi.org/10.1038/s44318-026-00854-5
Source records
- crossref · retrieved 2026-09-26T13:17:19.812Z